Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

755756

registered interest
date	04/09/2017
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Academies: Pay
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, how many and which heads of multi-academy trusts earn more than £150,000 per annum.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7379
answer	answer is ministerial correction date of answer 07/09/2017 answer text <p>A list of academy trusts paying staff more than £150,000 will be included in the 2015/16 Academy Sector Annual Report and Accounts (SARA), which is due to be published in October 2017. The information however does not contain the names of the employees, as the data is not reported through the academy accounts.</p><p>Academy trusts are responsible for setting their own remuneration for staff. It is essential that we have the best people to lead our schools if we are to raise standards, but we expect pay to be commensurate with the size of the trust and performance. Most academy leaders earn under £110k – the national maximum (excluding London) of the pay range for the leadership group<strong>.</strong></p><p>Trusts must disclose senior staff pay annually in their audited accounts. The Education and Skills Funding Agency follows up, on a risk basis, where non-compliance is identified.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill question first answered 07/09/2017 16:14:38 answering member 1562 label Biography information for Sir Robert Goodwill
tabling member	1566 label Biography information for Daniel Kawczynski

755799

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps are being taken to improve definitions of myalgic encephalomyelitis for diagnosis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7179
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7180 7181 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755800

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what training is provided for doctors to help them treat patients with myalgic encephalomyelitis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7180
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7181 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755801

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients received NHS treatment for myalgic encephalomyelitis in the last 12 months.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7181
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7180 7593 7594 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

755802

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding is provided each year for research into myalgic encephalomyelitis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7182
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>The Department’s National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including myalgic encephalomyelitis (ME); it is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity. Currently, the NIHR is funding one project on ME; a large randomised controlled trial of an internet-based cognitive behavioural therapy for children aged 11-17 years. It is being led by Professor Esther Crawley at Bristol University and is funded for £994,430. It began in May 2016 and further information on this, and all NIHR funded projects, can be found at:</p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/hta/14192109/#/summary-of-research" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/hta/14192109/#/summary-of-research</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 12/09/2017 15:04:03 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1566 label Biography information for Daniel Kawczynski

755808

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Sclerosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients the NHS is treating for multiple sclerosis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7178
answer	answer is ministerial correction date of answer 08/09/2017 answer text <p>This information is not available. The National Institute for Health and Care Excellence estimates that multiple sclerosis affects around 100,000 people in the United Kingdom.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/09/2017 11:40:53 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

756060

registered interest
date	04/09/2017
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Aviation: Tickets
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what assessment he has made of the (a) effect on passengers and (b) extent of airlines overbooking flights; and if he will make a statement.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7378
answer	answer is ministerial correction date of answer 07/09/2017 answer text <p>The Government undertook impact assessments regarding Regulation (EC) 261/2004, which covers passengers’ rights in the event of denied boarding, at the point of its initial negotiation, and as part of subsequent efforts to reform the Regulation. Both of these issues were within the scope of that assessment.</p><p> </p><p>To protect consumers, financial penalties on the industry through regulation has provided a deterrent to overbooking.</p><p> </p><p>In addition the Government and the CAA have introduced an Alternative Dispute Resolution (ADR) scheme into the sector, which now covers more than 70% of passengers.</p><p> </p><p>We have also begun the process of developing a new strategy for UK aviation. This strategy will put the consumer back at the heart of our thinking and ensure that the sector is delivering for consumers and the country as a whole.</p><p> </p> answering member constituency South Holland and The Deepings answering member printed Mr John Hayes question first answered 07/09/2017 15:30:29 answering member 350 label Biography information for Sir John Hayes
tabling member	1566 label Biography information for Daniel Kawczynski

756655

registered interest
date	04/09/2017
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Beer: Excise Duties
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, if he will freeze beer duty for the remainder of the current Parliament.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7572
answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>The government keeps all taxes under review at fiscal events, and we will consider this issue carefully as part of the Autumn Budget process.</p> answering member constituency Harrogate and Knaresborough answering member printed Andrew Jones question first answered 12/09/2017 10:13:03 answering member 3996 label Biography information for Andrew Jones
tabling member	1566 label Biography information for Daniel Kawczynski

756656

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of guidelines on myalgic encephalomyelitis published by health authorities in (a) Canada and (b) other countries.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7595
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7180 7181 7593 7594 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski

756657

registered interest
date	04/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to provide doctors with up-to-date information on the treatment of patients with myalgic encephalomyelitis.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	7594
answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>Information on the exact number of patients receiving treatment for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is not collected. The National Institute for Health and Care Excellence (NICE) clinical guideline, ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children estimates that the annual prevalence is approximately 4,000 cases per million of the population.</p><p>The NICE clinical guideline set outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and supports commissioners to to plan services for local populations. NICE routinely reviews its guidance to ensure it reflects the latest available evidence, including international evidence. In spring 2017, NICE reviewed the CFS/ME guideline to assess whether new research on CCFS/ME would impact on the current guideline recommendations. This included looking at new evidence concerning diagnostic criteria. Having assessed the evidence, NICE published its provisional recommendation not to update the NICE guideline for consultation on 10 July for a period of two weeks. NICE’s final recommendation is expected in October 2017.</p><p> </p><p>In terms of training, the General Medical Council sets out the knowledge, skills and behaviours that new United Kingdom medical graduates must be able to demonstrate and Royal Medical Colleges, such as the Royal College of General Practitioners (RCGP) set the standards for postgraduate medical education in general practice. General practice is where most patients with CFS/ME are likely to be managed, and the condition is identified as a key area of clinical knowledge in the RCGP Applied Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the UK within the context of the National Health Service and is a key part of general practitioner’s (GPs) qualifying exams.</p><p> </p><p>Once fully qualified, clinicians are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance, such as that produced by NICE.</p><p>The Department has made no assessment has been made of guidelines on CFS/ME published by health authorities in Canada and other countries.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7179 7180 7181 7593 7595 question first answered 11/09/2017 16:08:57 answering member 4067 label Biography information for Steve Brine
tabling member	1566 label Biography information for Daniel Kawczynski